Compared with controls, LOAD patients showed a higher number of females (64% vs. 53%, respectively) and APOE ε4 carriers (39% vs. 15%, respectively), less hypertension rate (38% vs. 53%, respectively) and hypercholesterolemia (18% vs. 31%, respectively). This evidence concerns the gene APOE and Hypercholesterolemia.